Anti-Cancer Drugs


ISSN: 0959-4973        年代:2003
当前卷期:Volume 14  issue 8     [ 查看所有卷期 ]

年代:2003
 
     Volume 14  issue 1   
     Volume 14  issue 2   
     Volume 14  issue 3   
     Volume 14  issue 4   
     Volume 14  issue 5   
     Volume 14  issue 6   
     Volume 14  issue 7   
     Volume 14  issue 8
     Volume 14  issue 9   
     Volume 14  issue 10   
1. Virotherapeutics: conditionally replicative adenoviruses for viral oncolysis
  Anti-Cancer Drugs,   Volume  14,   Issue  8,   2003,   Page  577-584

Dirk Nettelbeck,  

Preview   |   PDF (279KB)

2. TT-232: a somatostatin structural derivative as a potent antitumor drug candidate
  Anti-Cancer Drugs,   Volume  14,   Issue  8,   2003,   Page  585-588

B. Szende,   Gy. Kéri,  

Preview   |   PDF (69KB)

3. Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study
  Anti-Cancer Drugs,   Volume  14,   Issue  8,   2003,   Page  589-594

M. S. Stratton,   M. E. Reid,   G. Schwartzberg,   F. E. Minter,   B. K. Monroe,   D. S. Alberts,   J. R. Marshall,   F. R. Ahmann,  

Preview   |   PDF (92KB)

4. Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the ‘Watchful Waiting’ Study
  Anti-Cancer Drugs,   Volume  14,   Issue  8,   2003,   Page  595-600

M. S. Stratton,   M. E. Reid,   G. Schwartzberg,   F. E. Minter,   B. K. Monroe,   D. S. Alberts,   J. R. Marshall,   F. R. Ahmann,  

Preview   |   PDF (98KB)

5. Synthesis and biological evaluation of novel diaziridinylquinone–acridine conjugates
  Anti-Cancer Drugs,   Volume  14,   Issue  8,   2003,   Page  601-615

Angela Di Francesco,   Stephen Mayalarp,   Susan Kim,   John Butler,   Moses Lee,  

Preview   |   PDF (288KB)

6. Antitumor activity of the alkylating oligopeptides J1 (L-melphalanyl-p-L-fluorophenylalanine ethyl ester) and P2 (L-prolyl-m-L-sarcolysyl-p-L-fluorophenylalanine ethyl ester): comparison with melphalan
  Anti-Cancer Drugs,   Volume  14,   Issue  8,   2003,   Page  617-624

Joachim Gullbo,   Sumeer Dhar,   Kristina Luthman,   Hans Ehrsson,   Rolf Lewensohn,   Peter Nygren,   Rolf Larsson,  

Preview   |   PDF (140KB)

7. TEL-fusion oncogenic tyrosine kinases determine leukemic cells response to idarubicin
  Anti-Cancer Drugs,   Volume  14,   Issue  8,   2003,   Page  625-631

Ireneusz Majsterek,   Artur Slupianek,   Janusz Blasiak,  

Preview   |   PDF (156KB)

8. Phase I study of liposomal doxorubicin and oxaliplatin as salvage chemotherapy in advanced ovarian cancer
  Anti-Cancer Drugs,   Volume  14,   Issue  8,   2003,   Page  633-638

Francesco Recchia,   Sandro Filippis,   Gaetano Saggio,   Giovanna Amiconi,   Alisia Cesta,   Gaspare Carta,   Silvio Rea,  

Preview   |   PDF (99KB)

9. Randomized clinical trial of adenosine 5′-triphosphate on tumor growth and survival in advanced lung cancer patients
  Anti-Cancer Drugs,   Volume  14,   Issue  8,   2003,   Page  639-644

Hendrik Agteresch,   Sjaak Burgers,   Ate van der Gaast,   J. H. Paul Wilson,   Pieter Dagnelie,  

Preview   |   PDF (111KB)

10. Weekly treatment with irinotecan, folinic acid and infusional 5-fluorouracil (ILF) in patients with advanced gastric cancer
  Anti-Cancer Drugs,   Volume  14,   Issue  8,   2003,   Page  645-650

Markus Moehler,   Ulrike Haas,   Juergen Siebler,   Christoph Schimanski,   Christian Hertkorn,   Thomas Hoehler,   Peter Galle,   Michael Heike,  

Preview   |   PDF (93KB)

首页 上一页 下一页 尾页 第1页 共15条